Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
The Laryngoscope|July 3, 2003
Expression of hypoxia inducible factor 1 alpha and Von Hippel Lindau protein in human middle ear cholesteatomaOliver Adunka, Wolfgang Gstoettner, Rainald Knecht, et al.
Acta Oto-Laryngologica|June 22, 2005
Surgical considerations in cochlear implantation in children and adults: a review of 342 cases in ViennaChristoph Arnoldner, Wolf Dieter Baumgartner, Wolfgang Gstoettner, et al.
Ear and Hearing|May 9, 2007
Application of a corticosteroid (Triamcinolon) protects inner ear function after surgical interventionQing Ye, Jochen Tillein, Rainer Hartmann, et al.
International Journal of Audiology|March 24, 2004
Speech perception with a cochlear implant used in conjunction with a hearing aid in the opposite earJafar Hamzavi, Stefan Marcel Pok, Wolfgang Gstoettner, et al.
International Journal of Audiology|August 11, 2017
Speech perception with a cochlear implant used in conjunction with a hearing aid in the opposite earJafar Hamzavi, Stefan Marcel Pok, Wolfgang Gstoettner, et al.
The Annals of Otology, Rhinology, and Laryngology|March 7, 2006
AdOnco: a database for clinical and scientific documentation of head and neck oncologyMarkus Hambek, Oliver Adunka, Mehran Baghi, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|May 7, 2004
Application of carbon dioxide and erbium:yttrium-aluminum-garnet lasers in inner ear surgery: an experimental studyJan Kiefer, Jochen Tillein, Qing Ye, et al.
The Laryngoscope|July 6, 2004
Development and evaluation of an improved cochlear implant electrode design for electric acoustic stimulationOliver Adunka, Jan Kiefer, Marc H Unkelbach, et al.
Acta Oto-Laryngologica|June 12, 2003
Variables affecting speech perception in postlingually deaf adults following cochlear implantationJafar Hamzavi, Wolf-Dieter Baumgartner, Stefan Marcel Pok, et al.
Anticancer Research|June 3, 2006
A phase II trial of docetaxel, cisplatin and 5-fluorouracil in patients with recurrent squamous cell carcinoma of the head and neck (SCCHN)Mehran Baghi, Markus Hambek, Jens Wagenblast, et al.
Pageof 6